T2 Biosystems: To The Moon?

We take a look at the wild ride in T2 Biosytems and how to play this $2.50 medical diagnostic stock

*If you found this story via twitter, stocktwits or other medium and want to have these articles sent to you…

Today, we revisit a small diagnostic concern that has had one of the wildest rides in the market so far in 2019 of any of the small cap concerns I own. The shares are ‘back from the dead’ on a spate of recent good news for the company.

Comments


Bret Jensen
EditorBret Jensen
alexandra
Editoralexandra
New Comment
1
Bret Jensen
EditorBret Jensen
New Comment
allisondbl
1
Bret Jensen
EditorBret Jensen
New Comment
fadiwd
Bret Jensen
EditorBret Jensen
New Comment
Timothy Blackbread
alexandra
Editoralexandra
New Comment
Bret Jensen
EditorBret Jensen
New Comment
altheqa